News

Deal Announcements

Qvella Lands Series A Venture Financing

Monday, November 2, 2015 5:39:00 AM PDT | VentureDeal
   Richmond Hill, Canada  --  Biotechnology company Qvella has garnered $20 million in its Series A round of venture capital funding.

Qvella is a molecular diagnostics company that has developed a technology for pathogen detection by "direct sampling of bodily fluids without the need for culturing or time-consuming sample processing."

RA Capital led the round, which included other undisclosed investors.

Qvella said that it will use the capital to support its research and development efforts and continue to build out its team.

CEO Tino Alavie co-founded the company in 2010.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1